Nemr Elie, El Helou Elie, Mjaess Georges, Semaan Albert, Chebel Josselin Abi
Université Saint Joseph, Faculty of Medicine, Beirut, Lebanon.
Adv Urol. 2020 Jan 13;2020:6325490. doi: 10.1155/2020/6325490. eCollection 2020.
Phytotherapy for lower urinary tract symptoms (LUTSs) due to benign prostate hyperplasia (BPH) is progressively demanded by patients and trusted by physicians. The aim was to assess the efficacy of a mix of pumpkin seed extract, soy germ isoflavonoids, and cranberry (Novex®) in the management of mild to moderate LUTS in BPH patients. Male patients aged ≥40 years, who had had mild to moderate LUTS for >6 months at screening, with no previous therapy or who are still symptomatic despite current use of alpha-blockers, were recruited. Exclusion criteria were an IPSS >19 and an age >80 years. The mixed compound was administered orally, daily, for 3 months. Patients were evaluated by means of IPSS, urological quality of life (uQoL) index, and International Index of Erectile Function (IIEF-5) at 3 visits: baseline (visit 1), 30 days (visit 2), and 90 days after treatment (visit 3). Among 163 screened patients, 128 patients (61.8 ± 9.9 years) were recruited. IPSS improved from 15 (Q1 : 12-Q3 : 17) in visit 1, to 11 (Q1 : 8-Q3 : 14) in visit 2, and to 9 (Q1 : 6-Q3 : 12) in visit 3 ( < 0.001). uQoL improved from 4 (3-4) in visit 1, to 3 (2-3) in visit 2, and to 2 (1-2) in visit 3 ( < 0.001). The patients had an IIEF-5 score of 15 (12-18.7) in visit 1, 15 (12-18) in visit 2, and 17 (13-19) in visit 3 (=0.99 visits 1 vs. 2, =0.004 visits 2 vs. 3, and =0.001 visits 1 vs. 3). Treating mild to moderate LUTS/BPH patients with Novex® might therefore relieve symptoms, improve the quality of life, and have a mild beneficial effect on erectile function.
前列腺增生(BPH)所致下尿路症状(LUTS)的植物疗法越来越受到患者的需求并得到医生的信任。目的是评估南瓜籽提取物、大豆胚芽异黄酮和蔓越莓(Novex®)混合物对BPH患者轻度至中度LUTS的治疗效果。招募年龄≥40岁、筛查时轻度至中度LUTS持续>6个月、未曾接受过治疗或尽管目前使用α受体阻滞剂仍有症状的男性患者。排除标准为国际前列腺症状评分(IPSS)>19分且年龄>80岁。混合化合物每日口服给药,持续3个月。在3次就诊时通过IPSS、泌尿外科生活质量(uQoL)指数和国际勃起功能指数(IIEF-5)对患者进行评估:基线(第1次就诊)、30天(第2次就诊)和治疗后90天(第3次就诊)。在163名筛查患者中,招募了128名患者(61.8±9.9岁)。IPSS从第1次就诊时的15分(四分位间距:第1四分位数12 - 第3四分位数17)改善至第2次就诊时的11分(第1四分位数8 - 第3四分位数14),并在第3次就诊时改善至9分(第1四分位数6 - 第3四分位数12)(P<0.001)。uQoL从第1次就诊时的4分(3 - 4)改善至第2次就诊时的3分(2 - 3),并在第3次就诊时改善至2分(1 - 2)(P<0.001)。患者在第1次就诊时IIEF-5评分为15分(12 - 18.7),第2次就诊时为15分(12 - 18),第3次就诊时为17分(13 - 19)(第1次与第2次就诊比较P = 0.99,第2次与第3次就诊比较P = 0.004,第1次与第3次就诊比较P = 0.001)。因此,用Novex®治疗轻度至中度LUTS/BPH患者可能会缓解症状、改善生活质量,并对勃起功能有轻微有益影响。